The global diabetes clinical nutrition market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of diabetes and obesity, rising awareness about the benefits of dietary supplements for managing diabetes, and growing demand for natural ingredients in food products.
Tablets are expected to be the fastest-growing segment in the global diabetes clinical nutrition market during the forecast period. This growth can be attributed to their convenience and ease of use as compared with other types of formulations such as powders or liquids.
Some Of The Growth Factors Of This Market:
- The global population is aging, and the incidence of diabetes is increasing with age.
- The prevalence of obesity has increased in many countries, and obesity is a major risk factor for type 2 diabetes.
- Diabetes clinical nutrition market growth factors include the increase in chronic diseases such as diabetes, which are associated with an increased need for clinical nutrition products to manage these conditions.
- There are also new technologies that have been developed to help people manage their diabetes more effectively.
Industry Growth Insights published a new data on “Diabetes Clinical Nutrition Market”. The research report is titled “Diabetes Clinical Nutrition Market research by Types (Tablets, Capsules, Powders, Soft gels, Liquids, Others, ), By Applications (Hospital Pharmacies, Retail Pharmacies, Convenience Stores, Online Pharmacies, Others, ), By Players/Companies Newtrition Plus, Amber Lynn, Nestle S.A., Abbott Nutrition, Medlife, Danone, Fresenius Kabi, Zemaica Healthcare, Best Source Nutrition Pvt. Ltd.,, Inlife Pharma Pvt. Ltd., Kalbe Farma”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Diabetes Clinical Nutrition Market Research Report
By Type
Tablets, Capsules, Powders, Soft gels, Liquids, Others,
By Application
Hospital Pharmacies, Retail Pharmacies, Convenience Stores, Online Pharmacies, Others,
By Companies
Newtrition Plus, Amber Lynn, Nestle S.A., Abbott Nutrition, Medlife, Danone, Fresenius Kabi, Zemaica Healthcare, Best Source Nutrition Pvt. Ltd.,, Inlife Pharma Pvt. Ltd., Kalbe Farma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Diabetes Clinical Nutrition Market Report Segments:
The global Diabetes Clinical Nutrition market is segmented on the basis of:
Types
Tablets, Capsules, Powders, Soft gels, Liquids, Others,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Convenience Stores, Online Pharmacies, Others,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Newtrition Plus
- Amber Lynn
- Nestle S.A.
- Abbott Nutrition
- Medlife
- Danone
- Fresenius Kabi
- Zemaica Healthcare
- Best Source Nutrition Pvt. Ltd.,
- Inlife Pharma Pvt. Ltd.
- Kalbe Farma
Highlights of The Diabetes Clinical Nutrition Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablets
- Capsules
- Powders
- Soft gels
- Liquids
- Others
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Convenience Stores
- Online Pharmacies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Diabetes Clinical Nutrition Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Diabetes clinical nutrition is the application of scientific principles and evidence-based practice to help people with diabetes manage their blood sugar levels. It includes everything from developing meal plans and snacks to helping people monitor their blood sugar levels and adjust their medications as needed.
Some of the key players operating in the diabetes clinical nutrition market are Newtrition Plus, Amber Lynn, Nestle S.A., Abbott Nutrition, Medlife, Danone, Fresenius Kabi, Zemaica Healthcare, Best Source Nutrition Pvt. Ltd.,, Inlife Pharma Pvt. Ltd., Kalbe Farma.
The diabetes clinical nutrition market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Diabetes Clinical Nutrition Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Diabetes Clinical Nutrition Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Diabetes Clinical Nutrition Market - Supply Chain
4.5. Global Diabetes Clinical Nutrition Market Forecast
4.5.1. Diabetes Clinical Nutrition Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Diabetes Clinical Nutrition Market Size (000 Units) and Y-o-Y Growth
4.5.3. Diabetes Clinical Nutrition Market Absolute $ Opportunity
5. Global Diabetes Clinical Nutrition Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Diabetes Clinical Nutrition Market Size and Volume Forecast by Type
5.3.1. Tablets
5.3.2. Capsules
5.3.3. Powders
5.3.4. Soft gels
5.3.5. Liquids
5.3.6. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Diabetes Clinical Nutrition Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Diabetes Clinical Nutrition Market Size and Volume Forecast by Application
6.3.1. Hospital Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Convenience Stores
6.3.4. Online Pharmacies
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Diabetes Clinical Nutrition Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Diabetes Clinical Nutrition Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Diabetes Clinical Nutrition Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Diabetes Clinical Nutrition Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Diabetes Clinical Nutrition Demand Share Forecast, 2019-2026
9. North America Diabetes Clinical Nutrition Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Diabetes Clinical Nutrition Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Diabetes Clinical Nutrition Market Size and Volume Forecast by Application
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Convenience Stores
9.4.4. Online Pharmacies
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Diabetes Clinical Nutrition Market Size and Volume Forecast by Type
9.7.1. Tablets
9.7.2. Capsules
9.7.3. Powders
9.7.4. Soft gels
9.7.5. Liquids
9.7.6. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Diabetes Clinical Nutrition Demand Share Forecast, 2019-2026
10. Latin America Diabetes Clinical Nutrition Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Diabetes Clinical Nutrition Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Diabetes Clinical Nutrition Market Size and Volume Forecast by Application
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Convenience Stores
10.4.4. Online Pharmacies
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Diabetes Clinical Nutrition Market Size and Volume Forecast by Type
10.7.1. Tablets
10.7.2. Capsules
10.7.3. Powders
10.7.4. Soft gels
10.7.5. Liquids
10.7.6. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Diabetes Clinical Nutrition Demand Share Forecast, 2019-2026
11. Europe Diabetes Clinical Nutrition Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Diabetes Clinical Nutrition Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Diabetes Clinical Nutrition Market Size and Volume Forecast by Application
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Convenience Stores
11.4.4. Online Pharmacies
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Diabetes Clinical Nutrition Market Size and Volume Forecast by Type
11.7.1. Tablets
11.7.2. Capsules
11.7.. Powders
11.7.4. Soft gels
11.7.5. Liquids
11.7.6. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Diabetes Clinical Nutrition Demand Share, 2019-2026
12. Asia Pacific Diabetes Clinical Nutrition Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Diabetes Clinical Nutrition Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Diabetes Clinical Nutrition Market Size and Volume Forecast by Application
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Convenience Stores
12.4.4. Online Pharmacies
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Diabetes Clinical Nutrition Market Size and Volume Forecast by Type
12.7.1. Tablets
12.7.2. Capsules
12.7.3. Powders
12.7.4. Soft gels
12.7.5. Liquids
12.7.6. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Diabetes Clinical Nutrition Demand Share, 2019-2026
13. Middle East & Africa Diabetes Clinical Nutrition Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Diabetes Clinical Nutrition Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Diabetes Clinical Nutrition Market Size and Volume Forecast by Application
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Convenience Stores
13.4.4. Online Pharmacies
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Diabetes Clinical Nutrition Market Size and Volume Forecast by Type
13.7.1. Tablets
13.7.2. Capsules
13.7.3. Powders
13.7.4. Soft gels
13.7.5. Liquids
13.7.6. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Diabetes Clinical Nutrition Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Diabetes Clinical Nutrition Market: Market Share Analysis
14.2. Diabetes Clinical Nutrition Distributors and Customers
14.3. Diabetes Clinical Nutrition Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Newtrition Plus
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Amber Lynn
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Nestle S.A.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Abbott Nutrition
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Medlife
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Danone
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Fresenius Kabi
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Zemaica Healthcare
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Best Source Nutrition Pvt. Ltd.,
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Inlife Pharma Pvt. Ltd.
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Kalbe Farma
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
